Literature DB >> 1572968

Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

T Zhang1, C A Mauracher, L A Mitchell, A J Tingle.   

Abstract

Immunoblot (IB) assays were developed for detection of rubella virus (RV)-specific immunoglobulin G (IgG), IgM, and IgA antibodies in human serum following natural infection or immunization. IB assays performed under nonreducing conditions were compared with those performed under reducing conditions and with immunoprecipitation assays. Significant loss of antigenicity (greater than 90%) of RV E1 and E2 proteins was observed when IB assays were performed in the presence of 2-mercaptoethanol as compared with assays under nonreducing conditions. In contrast, the antigenicity of RV capsid protein was not influenced by reducing agents. Sensitivity of IB for RV-specific IgG antibodies was determined to be 0.01 IU/ml under nonreducing conditions. In the determination of RV-specific IgM and IgA antibodies by IB, pretreatment of serum with protein G to remove competing high-affinity RV-specific IgG or rheumatoid factor significantly improved assay sensitivity. IB assays were observed to be superior to immunoprecipitation assays in their ability to better define the specificities of RV-specific antibodies and to detect antibodies of all immunoglobulin classes. However, the conformational sensitivity of RV protein antigenicity should be an important consideration in the interpretation of RV-specific antibodies by IB assays.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572968      PMCID: PMC265169          DOI: 10.1128/jcm.30.4.824-830.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

Review 1.  Subacute sclerosing panencephalitis, progressive rubella panencephalitis, and multifocal leukoencephalopathy.

Authors:  J S Wolinsky
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

2.  A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties.

Authors:  B Akerström; L Björck
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

3.  Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C.

Authors:  D M Clarke; T W Loo; I Hui; P Chong; S Gillam
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

4.  Comparison of five different methods of rubella IgM antibody testing.

Authors:  H Cubie; E Edmond
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

5.  Immunofluorescence test for IgM rubella antibodies in whole serum after absorption with anti-gammaFc.

Authors:  R Gispen; J Nagel; B Brand-Saathof; S De Graaf
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

Review 6.  Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.

Authors:  L A Burman; R Norrby; B Trollfors
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

7.  Antibody response to individual rubella virus proteins in congenital and other rubella virus infections.

Authors:  S Katow; A Sugiura
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

8.  Selective reactivity of antibodies to human immunoglobulins G, M, and A with rubella virus proteins.

Authors:  P Partanen; H Seppänen; J Suni; A Vaheri
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

9.  Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia.

Authors:  A J Tingle; J K Chantler; K H Pot; D W Paty; D K Ford
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

10.  Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome.

Authors:  A de Mazancourt; M N Waxham; J C Nicolas; J S Wolinsky
Journal:  J Med Virol       Date:  1986-06       Impact factor: 2.327

View more
  6 in total

1.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  A perspective on vaccine evaluation research in Canada: Past and future.

Authors:  D W Scheifele; A J Tingle
Journal:  Can J Infect Dis       Date:  1993-03

3.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

4.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Humoral immune response to primary rubella virus infection.

Authors:  Kim M Wilson; Carlie Di Camillo; Larissa Doughty; Elizabeth M Dax
Journal:  Clin Vaccine Immunol       Date:  2006-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.